Strata Critical Medical (SRTA) Non-Current Deffered Revenue (2019 - 2021)

Strata Critical Medical has disclosed Non-Current Deffered Revenue across 3 years of filings, most recently posting $9.6 million for Q1 2021.

• In Q1 2021, Non-Current Deffered Revenue changed 0.0% year-over-year to $9.6 million; the TTM figure through Mar 2021 stood at $9.6 million (changed 0.0% YoY), while the FY2020 annual figure was $9.6 million, changed N/A from the prior year.
• Non-Current Deffered Revenue held at $9.6 million in Q1 2021, from $9.6 million in the prior quarter.
• Over the last five years, Non-Current Deffered Revenue for SRTA reached as high as $9.6 million in Q3 2019 and fell as low as $9.6 million in Q3 2019.
• The 3-year median for Non-Current Deffered Revenue is $9.6 million (2019), against an average of $9.6 million.
• The widest YoY moves for Non-Current Deffered Revenue: up 0.0% in 2020, down 0.0% in 2020.
• A 3-year view of Non-Current Deffered Revenue shows it stood at $9.6 million in 2019, then changed by 0.0% to $9.6 million in 2020, then changed by 0.0% to $9.6 million in 2021.
• According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $9.6 million, $9.6 million, and $9.6 million for Q1 2021, Q4 2020, and Q3 2020 respectively.